MeSH D010335 - pathologic processes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013568:Signs and symptoms pathological conditions
0 Companies
0 Drugs
Success rate
D010335:
Pathologic processes
0 Companies
0 Drugs
Success rate
D000051:Acantholysis
0 Companies
0 Drugs
Success rate
D000069451:Long term adverse effects
0 Companies
0 Drugs
Success rate
D000073496:Frailty
0 Companies
0 Drugs
Success rate
D000081015:Ototoxicity
D000081028:Toxic optic neuropathy
0 Companies
0 Drugs
Success rate
D000081030:Myotoxicity
0 Companies
0 Drugs
Success rate
D001145:Cardiac arrhythmias
D001201:Ascites
D002869:Chromosome aberrations
0 Companies
0 Drugs
Success rate
D003643:Death
0 Companies
0 Drugs
Success rate
D003681:Dehydration
0 Companies
0 Drugs
Success rate
D004194:Disease
0 Companies
0 Drugs
Success rate
D004646:Emphysema
0 Companies
0 Drugs
Success rate
D005119:Extravasation of diagnostic and therapeutic materials
D005355:Fibrosis
0 Companies
0 Drugs
Success rate
D005911:Gliosis
0 Companies
0 Drugs
Success rate
D006099:Granuloma
0 Companies
0 Drugs
Success rate
D006130:Growth disorders
D006470:Hemorrhage
D006965:Hyperplasia
0 Companies
0 Drugs
Success rate
D007249:Inflammation
D007431:Intraoperative complications
D007511:Ischemia
0 Companies
0 Drugs
Success rate
D007964:Leukocytosis
D008287:Malacoplakia
0 Companies
0 Drugs
Success rate
D008599:Menstruation disturbances
D008679:Metaplasia
0 Companies
0 Drugs
Success rate
D009336:Necrosis
D009410:Nerve degeneration
0 Companies
0 Drugs
Success rate
D009794:Ochronosis
0 Companies
0 Drugs
Success rate
D009999:Heterotopic ossification
D010859:Pigmentation disorders
0 Companies
0 Drugs
Success rate
D011183:Postoperative complications
D012188:Retropneumoperitoneum
0 Companies
0 Drugs
Success rate
D012598:Sclerosis
0 Companies
0 Drugs
Success rate
D012769:Shock
D016710:Yin deficiency
0 Companies
0 Drugs
Success rate
D016711:Yang deficiency
0 Companies
0 Drugs
Success rate
D020347:Lithiasis
D020896:Hypovolemia
0 Companies
0 Drugs
Success rate
D020969:Disease attributes
0 Companies
0 Drugs
Success rate
D022124:Hyperammonemia
D033461:Hyperuricemia
D034321:Hyperamylasemia
0 Companies
0 Drugs
Success rate
D042822:Genomic instability
0 Companies
0 Drugs
Success rate
D049292:Leukoaraiosis
0 Companies
0 Drugs
Success rate
D051261:Orofacial granulomatosis
0 Companies
0 Drugs
Success rate
D051799:Delayed graft function
0 Companies
0 Drugs
Success rate
D053099:Azotemia
0 Companies
0 Drugs
Success rate
D053120:Respiratory aspiration
0 Companies
0 Drugs
Success rate
D053447:Channelopathies
0 Companies
0 Drugs
Success rate
D057925:Femoracetabular impingement
0 Companies
0 Drugs
Success rate
D058426:Neointima
0 Companies
0 Drugs
Success rate
D059606:Polydipsia
0 Companies
0 Drugs
Success rate
D064752:Atrial remodeling
0 Companies
0 Drugs
Success rate
D064793:Teratogenesis
0 Companies
0 Drugs
Success rate
D064806:Dysbiosis
0 Companies
0 Drugs
Success rate
D066126:Cardiotoxicity
0 Companies
0 Drugs
Success rate
D066253:Vascular remodeling
0 Companies
0 Drugs
Success rate
D066263:Pathological protein aggregation
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/4
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use